Physician profile
Cosette E Saba
NPI 1891162368
$3,136.54
in general payments reported to CMS, 2019-2025
5 companies · $90.95 in 2025
The $90.95 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $241 · 2022: $174 · 2023: $2,550 · 2024: $79.78 · 2025: $90.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,513 · Food and Beverage: $1,199 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,513.18 |
| Food and Beverage | $1,199.04 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $2,682.45 | 2021-2024 | Xeomin |
| Abbvie INC. | $232.30 | 2023 | |
| Allergan, INC. | $113.41 | 2021 | |
| Revance Therapeutics, INC. | $90.95 | 2025 | Daxxify |
| Currax Pharmaceuticals LLC | $17.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cosette Saba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.